Works matching IS 0340-7004 AND VI 74 AND IP 2 AND DT 2025

Results: 36

Correction: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal.

Published in:

2025

By:

Li, Xinya;
Song, Zaiwei;
Chen, Yixuan;
Wu, Jingjing;
Jiang, Dan;
Zhang, Zhen;
Wang, Zeyuan;
Zhao, Rongsheng

Publication type:

Correction Notice

IDO1 inhibitor enhances the effectiveness of PD-1 blockade in microsatellite stable colorectal cancer by promoting macrophage pro-inflammatory phenotype polarization.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03925-w

By:

Guangzhao, Lv;
Xin, Wang;
Miaoqing, Wu;
Wenjuan, Ma;
Ranyi, Liu;
Zhizhong, Pan;
Rongxin, Zhang;
Gong, Chen

Publication type:

Article

CircRNA-loaded DC vaccine in combination with low-dose gemcitabine induced potent anti-tumor immunity in pancreatic cancer model.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03924-x

By:

Cai, Zongyu;
Wuri, Qimuge;
Song, Yang;
Qu, Xueli;
Hu, Haotong;
Cao, Simiao;
Wu, Hui;
Wu, Jiaxin;
Wang, Chu;
Yu, Xianghui;
Kong, Wei;
Zhang, Haihong

Publication type:

Article

Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03923-y

By:

Lee, Juheon;
Song, Jinhoo;
Yoo, Wonbeak;
Choi, Hyunji;
Jung, Dana;
Choi, Eunjeong;
Jo, Seo-Gyeong;
Gong, Eun-Yeung;
Jeoung, Young-Hee;
Park, You-Soo;
Son, Woo-Chang;
Lee, Hosuk;
Lee, Hayoung;
Kim, Jeom Ji;
Kim, TaeEun;
Lee, Sooyun;
Park, Jang-June;
Kim, Tae-Don;
Kim, Seok-Ho

Publication type:

Article

TDO2 + cancer-associated fibroblasts mediate cutaneous squamous cell carcinoma immune escape via impeding infiltration of CD8 + T cells.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03921-0

By:

Lu, Fangqi;
Yan, Guorong;
Zhao, Zijun;
Zheng, Zhe;
Wu, Yuhao;
Wen, Long;
Liu, Yeqaing;
Zeng, Qingyu;
Zhang, Guolong

Publication type:

Article

Unsupervised clustering reveals noncanonical myeloid cell subsets in the brain tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03920-1

By:

Hermelo, Ismaïl;
Virtanen, Tuomo;
Salonen, Iida;
Nätkin, Reetta;
Keitaanniemi, Sofia;
Tiihonen, Aliisa M.;
Lehtipuro, Suvi;
Kummola, Laura;
Raulamo, Ella;
Nordfors, Kristiina;
Haapasalo, Hannu;
Rauhala, Minna;
Kesseli, Juha;
Nykter, Matti;
Haapasalo, Joonas;
Rautajoki, Kirsi

Publication type:

Article

Understanding the impact of spatial immunophenotypes on the survival of endometrial cancer patients through the ProMisE classification.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03919-8

By:

Hattori, Satomi;
Yoshikawa, Nobuhisa;
Liu, Wenting;
Matsukawa, Tetsuya;
Kubokawa, Mei;
Yoshida, Kosuke;
Yoshihara, Masato;
Tamauchi, Satoshi;
Ikeda, Yoshiki;
Yokoi, Akira;
Shimizu, Yusuke;
Niimi, Kaoru;
Kajiyama, Hiroaki

Publication type:

Article

Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03917-w

By:

Ren, Zhenggang;
Shao, Guoliang;
Shen, Jie;
Zhang, Li;
Zhu, Xu;
Fang, Weijia;
Sun, Guoping;
Bai, Yuxian;
Wu, Jianbing;
Liu, Lianxin;
Yuan, Yuan;
Zhang, Jingdong;
Li, Zhen;
Zhang, Ling;
Yin, Tao;
Wu, Jincai;
Hou, Xiaoli;
Yu, Haoyu;
Li, Jing;
Wang, Qingyu

Publication type:

Article

Tumor-colonizing Lachnoclostridium-mediated chemokine expression enhances the immune infiltration of bladder urothelial carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03916-x

By:

Chen, Liang;
Xu, Qingquan;
Chen, Weinan;
Liu, Jun;
Xu, Tao;
Yang, Jialiang;
Ji, Lei

Publication type:

Article

STC1 encapsulated in small extracellular vesicles from laryngeal squamous cell carcinoma cells induces CD8+ T cell dysfunction by reprogramming tumor-associated macrophages into M2-like macrophages.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03915-y

By:

Chen, Xiaoxue;
Zhao, Zhigang;
Zhao, Rui;
Li, Wenjing;
Liu, Xinyu;
Tian, Linli;
Liu, Ming

Publication type:

Article

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03911-2

By:

Westbom-Fremer, Sofia;
Tran, Lena;
Ebbesson, Anna;
Martin de la Fuente, Laura;
Jönsson, Jenny-Maria;
Kannisto, Päivi;
Veerla, Srinivas;
Hedenfalk, Ingrid

Publication type:

Article

CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03909-w

By:

Tian, Yonggui;
Zhang, Liubo;
Ping, Yu;
Zhang, Zhen;
Yao, Chang;
Shen, Chunyi;
Li, Feng;
Wen, Chunli;
Zhang, Yi

Publication type:

Article

Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03908-x

By:

Lenz, Jennifer A.;
Peng, Brandon;
Assenmacher, Charles‑Antoine;
King, Austin;
Zhang, Paul J.;
Maki, Robert G.;
Blanco, M. Andres;
Radaelli, Enrico;
Atherton, Matthew J.

Publication type:

Article

Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03907-y

By:

Oliveri, Franziska;
Neher, Linda;
Pscheid, Ronja;
Sewald, Isabel;
Gowdavally, Sowmya;
Betzler, Annika C.;
Hallitsch, Jaqueline;
Greve, Jens;
Laban, Simon;
Schmid, Sebastian;
Hoffmann, Thomas K.;
Schuler, Patrick J.;
Brunner, Cornelia

Publication type:

Article

Efficacy and safety of PD-1 blockade-activated neoantigen specific cellular therapy for advanced relapsed non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03906-z

By:

Qiao, Yun;
Hui, Kaiyuan;
Hu, Chenxi;
Wang, Mei;
Sun, Wen;
Liu, Liang;
Dong, Changhong;
Jiang, Xiaodong

Publication type:

Article

Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167).

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03905-0

By:

Li, Yuantai;
Min, Yu;
Wei, Zhigong;
Liu, Zheran;
Pei, Yiyan;
Yang, Yujie;
Gao, Kun;
Song, Ge;
Xu, Shihong;
He, Shuangshuang;
Ge, Junyou;
Qing, Yan;
Wei, Youneng;
Ai, Ping;
Chen, Ye;
Peng, Xingchen

Publication type:

Article

Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03904-1

By:

Wu, Peng;
Qin, Guohui;
Liu, Jinyan;
Zhao, Qitai;
Zhao, Xueke;
Song, Xin;
Wang, Lidong;
Yang, Shengli;
Zhang, Yi

Publication type:

Article

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03903-2

By:

Takao, Seiichiro;
Fukushima, Hiroshi;
Furusawa, Aki;
Kato, Takuya;
Okuyama, Shuhei;
Kano, Makoto;
Yamamoto, Hiroshi;
Suzuki, Motofumi;
Kano, Miyu;
Choyke, Peter L.;
Kobayashi, Hisataka

Publication type:

Article

Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03902-3

By:

Ploch, Michelle;
Zhao, Songzhu;
Wei, Lai;
Englert, Joshua A.;
Cohen, Sarah P.;
Inks, Morgan A.;
Meara, Alexa S.;
Fussner, Lynn A.;
Owen, Dwight H.;
Ho, Kevin

Publication type:

Article

Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results.

Published in:

2025

By:

Zenatri, Morgan;
Collins, Michael;
Alberto, Tifanie;
Farina, Antonio;
Collardeau-Frachon, Sophie;
Saint-Jean, Mélanie;
Bocquet, François;
Dumont, Frederic;
Honnorat, Jérôme;
Joubert, Bastien;
Raimbourg, Judith

Publication type:

Case Study

Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03899-9

By:

Chen, Yanxin;
Luo, Yuxi;
Liu, Yunwei;
Luo, Daya;
Liu, Anwen

Publication type:

Article

First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03897-x

By:

Roviello, Giandomenico;
Molina-Cerrillo, Javier;
Massari, Francesco;
Cerbone, Linda;
Fiala, Ondrej;
Fornarini, Giuseppe;
Monteiro, Fernando Sabino Marques;
Cattrini, Carlo;
Landmesser, Johannes;
Messina, Carlo;
Zgura, Anca;
Rebuzzi, Sara Elena;
Soares, Andrey;
Carrozza, Francesco;
Ansari, Jawaher;
Grillone, Francesco;
Küronya, Zsófia;
Incorvaia, Lorena;
Bhuva, Dipen;
Ortega, Cinzia

Publication type:

Article

Spatial expression of fibroblast activation protein-α in clear cell renal cell carcinomas revealed by multiplex immunoprofiling analysis of the tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03896-y

By:

Larrinaga, Gorka;
Redrado, Miriam;
Loizaga-Iriarte, Ana;
Pérez-Fernández, Amparo;
Santos-Martín, Aida;
Angulo, Javier C.;
Fernández, José A.;
Calvo, Alfonso;
López, José I.

Publication type:

Article

Transferrin receptor uptakes iron from tumor-associated neutrophils to regulate invasion patterns of OSCC.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03894-0

By:

Si, Qian;
Wang, Yuhan;
Lu, Wanqiu;
Liu, Zijian;
Song, Yuxian;
Chen, Sheng;
Xia, Shu;
Li, Huiling;
Weng, Pei;
Jing, Yue;
Yu, Qiuya;
Zhu, Feng;
Zhang, Xiaoxin;
Huang, Xiaofeng;
Ni, Yanhong

Publication type:

Article

Therapeutic effect of fully human anti-Nrp-1 antibody on non–small cell lung cancer in vivo and in vitro.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03893-1

By:

Zhang, Bo;
Liu, Qin;
Li, Lin;
Ye, Yingchun;
Guo, Xiyuan;
Xu, Wenfeng;
Chen, Ligang;
Mo, Xianming;
Nian, Siji;
Yuan, Qing

Publication type:

Article

Prognostic relevance of CD163+ immune cells in patients with metastatic breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03892-2

By:

Lindberg, Ida;
Saleh, Aya;
Tutzauer, Julia;
Gunnarsdottir, Frida Björk;
Rydén, Lisa;
Bergenfelz, Caroline;
Larsson, Anna-Maria

Publication type:

Article

Prognostic immune markers in esophageal cancer patients managed with trimodal therapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03891-3

By:

Farrugia, Mark K.;
Repasky, Elizabeth A.;
Chen, Minhui;
Attwood, Kristopher;
Catalfamo, Kayla;
Rosenheck, Hanna;
Yao, Song;
Mattson, David M.;
Mukherjee, Sarbajit;
Kukar, Moshim;
Witkiewicz, Agnieszka K.;
Singh, Anurag K.

Publication type:

Article

Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03890-4

By:

Sumi, Toshiyuki;
Nagano, Yutaro;
Yokoo, Keiki;
Ishikawa, Tatsuru;
Nishikiori, Hirotaka;
Honjo, Osamu;
Kudo, Sayaka;
Yamazoe, Masami;
Kondoh, Shun;
Shioya, Makoto;
Otsuka, Mitsuo;
Hashimoto, Midori;
Yabe, Hayato;
Tanaka, Yusuke;
Sudo, Yuta;
Yanagi, Masahiro;
Takahashi, Mamoru;
Chiba, Hirofumi

Publication type:

Article

Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03889-x

By:

D'Alonzo, Rebecca A.;
Keam, Synat;
Gill, Suki;
Rowshanfarzad, Pejman;
Nowak, Anna K.;
Ebert, Martin A.;
Cook, Alistair M.

Publication type:

Article

FcRn-guided antigen trafficking enhances cancer vaccine efficacy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03888-y

By:

Hong, Mengyu;
Liu, Muziying;
Zhu, Fang;
Zhao, Dan;
Liu, Guilai;
Han, Tiyun;
Fei, Caiyi;
Zeng, Weihong;
Chen, Shi;
Wu, Qiqin;
Li, Bofeng;
Wu, Songquan;
Shang, Yuhua;
Ma, Huan;
Zhou, Shoubing;
Xu, Shi;
Jin, Tengchuan

Publication type:

Article

Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03882-4

By:

Akli, Assya;
Takam Kamga, Paul;
Julie, Catherine;
Capron, Claude;
Costantini, Adrien;
Dumenil, Coraline;
Dumoulin, Jennifer;
Giraud, Violaine;
Parent, Florence;
Seferian, Andrei;
Guettier, Catherine;
Glorion, Mathieu;
Longchampt, Elisabeth;
Emile, Jean-François;
Giroux-Leprieur, Étienne

Publication type:

Article

High CD38 expression defines a mitochondrial function-adapted CD8+ T cell subset with implications for lung cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03881-5

By:

Lv, Lei-Lei;
Zhai, Jia-Wei;
Wu, Jia-Juan;
Fan, Gui-Qin;
Zhang, Yao-Xin;
Shen, Yu;
Qu, Qiu-Xia;
Chen, Cheng

Publication type:

Article

The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03878-0

By:

Tang, Cheng-Yu;
Lin, Yi-Ting;
Yeh, Yi-Chen;
Chung, Shin-Yi;
Chang, Yu-Chan;
Hung, Yi-Ping;
Chen, San-Chi;
Chen, Ming-Huang;
Chiang, Nai-Jung

Publication type:

Article

Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03876-2

By:

Ishihara, Hiroki;
Fukuda, Hironori;
Mizoguchi, Yukihiro;
Yamashita, Makiko;
Aoki, Kazunori;
Ishiyama, Ryo;
Ikeda, Takashi;
Nemoto, Yuki;
Shimmura, Hiroaki;
Hashimoto, Yasunobu;
Yoshida, Kazuhiko;
Hirai, Toshihito;
Iizuka, Junpei;
Tokita, Daisuke;
Kondo, Tsunenori;
Nagashima, Yoji;
Takagi, Toshio

Publication type:

Article

CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03859-3

By:

Strobel, Sophia B.;
Machiraju, Devayani;
Wiecken, Melanie;
Richter, Jasmin;
Klein, Julian A. F.;
Berger, Annemarie;
Hassel, Jessica C.

Publication type:

Article

Targeting immune checkpoints on myeloid cells: current status and future directions.

Published in:

2025

By:

Ma, Chuhan;
Li, Yang;
Li, Min;
Lv, Chao;
Tian, Yu

Publication type:

Literature Review

Works matching IS 0340-7004 AND VI 74 AND IP 2 AND DT 2025

Correction: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal.

IDO1 inhibitor enhances the effectiveness of PD-1 blockade in microsatellite stable colorectal cancer by promoting macrophage pro-inflammatory phenotype polarization.

CircRNA-loaded DC vaccine in combination with low-dose gemcitabine induced potent anti-tumor immunity in pancreatic cancer model.

Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer.

TDO2 + cancer-associated fibroblasts mediate cutaneous squamous cell carcinoma immune escape via impeding infiltration of CD8 + T cells.

Unsupervised clustering reveals noncanonical myeloid cell subsets in the brain tumor microenvironment.

Understanding the impact of spatial immunophenotypes on the survival of endometrial cancer patients through the ProMisE classification.

Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.

Tumor-colonizing Lachnoclostridium-mediated chemokine expression enhances the immune infiltration of bladder urothelial carcinoma.

STC1 encapsulated in small extracellular vesicles from laryngeal squamous cell carcinoma cells induces CD8<sup>+</sup> T cell dysfunction by reprogramming tumor-associated macrophages into M2-like macrophages.

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.

CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors.

Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma.

Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human disease.

Efficacy and safety of PD-1 blockade-activated neoantigen specific cellular therapy for advanced relapsed non-small cell lung cancer.

Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167).

Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinoma.

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies.

Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis.

Anti-PD1-/PDL1-induced chronic intestinal pseudo-obstruction: three cases treated with vedolizumab after corticosteroid failure with mixed results.

Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study.

First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.

Spatial expression of fibroblast activation protein-α in clear cell renal cell carcinomas revealed by multiplex immunoprofiling analysis of the tumor microenvironment.

Transferrin receptor uptakes iron from tumor-associated neutrophils to regulate invasion patterns of OSCC.

Therapeutic effect of fully human anti-Nrp-1 antibody on non–small cell lung cancer in vivo and in vitro.

Prognostic relevance of CD163<sup>+</sup> immune cells in patients with metastatic breast cancer.

Prognostic immune markers in esophageal cancer patients managed with trimodal therapy.

Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational study.

Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model.

FcRn-guided antigen trafficking enhances cancer vaccine efficacy.

Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer.

High CD38 expression defines a mitochondrial function-adapted CD8<sup>+</sup> T cell subset with implications for lung cancer immunotherapy.

The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer.

Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma.

CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patients.

Targeting immune checkpoints on myeloid cells: current status and future directions.